Reducing risk drives COST SAVINGS

An Academic Medical Center's Return on Investment


"The maximum potential cost savings for Temple University Hospital derived from eliminating post operative pulmonary complications associated with residual neuromuscular blockade would be roughly $7 million dollars annually.

This compares very favorably with an annual cost of implementing universal [TwitchView] quantitative train of four monitoring of $162,000."1

"This is a real opportunity for our specialty."

-Dr. Gordon Morewood, Chair and Professor of Anesthesiology at Temple University

LEARN how twitchView can REDUCE the COST of care AT YOUR FACILITY.

Subclinical residual neuromuscular blockade (RNMB) at the time of extubation increases the risk of post operative pulmonary complications between 2 and 3 times baseline2, 3

Residual Neuromuscular Blockade Increases the Cost of Care

costs icon-1-2-1

Respiratory Complications

The average surgical cost increases 12-fold to $62,704 for patients who experience post-operative respiratory complications4

billion icon-1

Unplanned ICU Admissions

Postoperative complications lead to an additional 92,000 ICU admissions and incur a cost of $3.42 billion each year5

pneumonia icon

Post-Operative Pneumonia

Patients that were not adequately reversed were twice as likely to develop pneumonia with a cost to treat of $6,042 per case6

Quantitative monitoring has been shown to reduce the incidence of RNMB from 62% to <4%7

submit the form

and start saving.


1. Edwards LM, Ly NK, Shinefeld J, Morewood GH. Universal Quantitative Neuromuscular Blockade Monitoring at an Academic Medical Center A Multimodal Analysis of the Potential Impact on Clinical Outcomes and Total Cost of Care. Abstract Poster Oct 2020, Anesthesiology 2020 Annual Meeting, Washington, D.C., United States.
2. Fortier LP, McKeen D, Turner K, et al. The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade. Anesth Analg . 2015;121(2):366 372. doi:10.1213/ANE.0000000000000757
3. Grabitz SD, Rajaratnam N, Chhagani K, et al. The Effects of Postoperative Residual Neuromuscular Blockade on Hospital Costs and Intensive Care Unit Admission: A Population Based Cohort Study. Anesthesia & Analgesia . 2019;128(6):1129 1136. doi: 10.1213/ANE.0000000000004028
4. Farhan H, Moreno-Duarte I, McLean D, Eikermann M. Residual Paralysis: Does it Influence Outcome After Ambulatory Surgery? Current Anesthesiology Reports. 2014;4(4):290-302.
5. Dimick JB, Chen SL, Taheri PA, Henderson WG, Khuri SF, Campbell DA. Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program. J Am Coll Surg. 2004;199(4):531–537.
6. Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. The cost of treating community-acquired pneumonia, Clin Ther. 1998; 20:820-37.
7. Naguib, M, et al. Consensus Statement on Perioperative Use of neuromuscular Monitoring. Anesth. Analg. 2018; 127(1):71-802